2024-11-06 |
2024-11-04 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
3,668
-2.1%
0.29
USD 1,064
|
3,668
-2.1%
|
0.29
|
USD 1,064
|
|
2024-08-02 |
2024-08-01 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
4,149
-2.3%
0.35
USD 1,452
|
4,149
-2.3%
|
0.35
|
USD 1,452
|
|
2024-05-06 |
2024-05-02 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
3,936
-2.2%
0.75
USD 2,952
|
3,936
-2.2%
|
0.75
|
USD 2,952
|
|
2024-04-09 |
2024-04-05 |
PS
Planned sale
|
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Officer
|
2,753
-3.0%
0.83
USD 2,285
|
2,753
-3.0%
|
0.83
|
USD 2,285
|
|
2024-04-09 |
2024-04-05 |
PS
Planned sale
|
Goncalves Joana
CHIEF MEDICAL OFFICER
Officer
|
2,753
-4.9%
0.83
USD 2,285
|
2,753
-4.9%
|
0.83
|
USD 2,285
|
|
2024-03-04 |
2024-02-29 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
5,834
-3.1%
0.89
USD 5,192
|
5,834
-3.1%
|
0.89
|
USD 5,192
|
|
2024-03-04 |
2024-02-29 |
PS
Planned sale
|
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Officer
|
3,293
-3.5%
0.89
USD 2,931
|
3,293
-3.5%
|
0.89
|
USD 2,931
|
|
2024-03-04 |
2024-02-29 |
PS
Planned sale
|
Goncalves Joana
CHIEF MEDICAL OFFICER
Officer
|
3,293
-5.5%
0.89
USD 2,931
|
3,293
-5.5%
|
0.89
|
USD 2,931
|
|
2024-02-12 |
2024-02-08 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
35,575
-16.0%
0.53
USD 18,855
|
35,575
-16.0%
|
0.53
|
USD 18,855
|
|
2024-02-05 |
2024-02-01 |
PS
Planned sale
|
Posner Christopher
PRESIDENT AND CEO
Executive Director
|
4,981
-2.2%
0.55
USD 2,740
|
4,981
-2.2%
|
0.55
|
USD 2,740
|
|
2023-11-03 |
2023-11-02 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
3,796
-2.3%
1.22
USD 4,631
|
3,796
-2.3%
|
1.22
|
USD 4,631
|
|
2023-08-04 |
2023-08-03 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
4,307
-2.5%
3.07
USD 13,222
|
4,307
-2.5%
|
3.07
|
USD 13,222
|
|
2023-06-27 |
2023-06-23 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
2,993
-1.9%
3.51
USD 10,505
|
2,993
-1.9%
|
3.51
|
USD 10,505
|
|
2023-06-27 |
2023-06-23 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,723
-4.8%
3.51
USD 9,558
|
2,723
-4.8%
|
3.51
|
USD 9,558
|
|
2023-06-27 |
2023-06-23 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
2,483
-2.7%
3.51
USD 8,715
|
2,483
-2.7%
|
3.51
|
USD 8,715
|
|
2023-05-09 |
2023-05-05 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
3,869
-2.2%
4.40
USD 17,024
|
3,869
-2.2%
|
4.40
|
USD 17,024
|
|
2023-04-06 |
2023-04-04 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
2,481
-2.7%
4.91
USD 12,182
|
2,481
-2.7%
|
4.91
|
USD 12,182
|
|
2023-04-06 |
2023-04-04 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
2,733
-1.7%
4.91
USD 13,419
|
2,733
-1.7%
|
4.91
|
USD 13,419
|
|
2023-04-06 |
2023-04-04 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,481
-4.2%
4.91
USD 12,182
|
2,481
-4.2%
|
4.91
|
USD 12,182
|
|
2023-03-07 |
2023-03-03 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
6,256
-6.3%
9.71
USD 60,746
|
6,256
-6.3%
|
9.71
|
USD 60,746
|
|
2023-03-07 |
2023-03-03 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
5,987
-3.3%
9.71
USD 58,134
|
5,987
-3.3%
|
9.71
|
USD 58,134
|
|
2023-03-07 |
2023-03-03 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
6,802
-4.1%
9.71
USD 66,047
|
6,802
-4.1%
|
9.71
|
USD 66,047
|
|
2023-03-07 |
2023-03-03 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
6,221
-9.6%
9.71
USD 60,406
|
6,221
-9.6%
|
9.71
|
USD 60,406
|
|
2023-02-17 |
2023-02-16 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,265
-3.4%
10.20
USD 23,103
|
2,265
-3.4%
|
10.20
|
USD 23,103
|
|
2024-02-12 |
2023-02-08 |
PS
Planned sale
|
Maynard Ryan D
CHIEF FINANCIAL OFFICER
Officer
|
5,488
-40.7%
0.53
USD 2,909
|
5,488
-40.7%
|
0.53
|
USD 2,909
|
|
2024-02-12 |
2023-02-08 |
PS
Planned sale
|
Goncalves Joana
CHIEF MEDICAL OFFICER
Officer
|
7,770
-11.6%
0.53
USD 4,118
|
7,770
-11.6%
|
0.53
|
USD 4,118
|
|
2024-02-12 |
2023-02-08 |
PS
Planned sale
|
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Officer
|
7,770
-7.6%
0.53
USD 4,118
|
7,770
-7.6%
|
0.53
|
USD 4,118
|
|
2023-02-03 |
2023-02-02 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
4,191
-2.2%
11.80
USD 49,454
|
4,191
-2.2%
|
11.80
|
USD 49,454
|
|
2023-01-19 |
2023-01-17 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,265
-3.3%
10.81
USD 24,485
|
2,265
-3.3%
|
10.81
|
USD 24,485
|
|
2023-01-03 |
2022-12-29 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,265
-3.2%
10.18
USD 23,058
|
2,265
-3.2%
|
10.18
|
USD 23,058
|
|
2022-12-23 |
2022-12-21 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
3,506
-2.1%
11.27
USD 39,513
|
3,506
-2.1%
|
11.27
|
USD 39,513
|
|
2022-12-23 |
2022-12-21 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
2,561
-2.5%
11.27
USD 28,862
|
2,561
-2.5%
|
11.27
|
USD 28,862
|
|
2022-12-23 |
2022-12-21 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,992
-4.0%
11.27
USD 33,720
|
2,992
-4.0%
|
11.27
|
USD 33,720
|
|
2022-11-18 |
2022-11-16 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
14,470
-7.2%
11.13
USD 161,051
|
14,470
-7.2%
|
11.13
|
USD 161,051
|
|
2022-09-16 |
2022-09-14 |
S
Sale
|
VOGELBAUM MARTIN
Non-Executive Director
|
10,800
-19.4%
10.28
USD 111,024
|
10,800
-19.4%
|
10.28
|
USD 111,024
|
|
2022-07-19 |
2022-07-15 |
PS
Planned sale
|
BAINS HARRISON M JR
Non-Executive Director
|
7,200
-22.3%
9.05
USD 65,160
|
7,200
-22.3%
|
9.05
|
USD 65,160
|
|
2022-07-19 |
2022-07-15 |
PS
Planned sale
|
Ives Jeffrey L.
Non-Executive Director
|
3,600
-18.9%
9.05
USD 32,580
|
3,600
-18.9%
|
9.05
|
USD 32,580
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Posner Christopher
President and CEO
Executive Director
|
2,006
-1.0%
12.67
USD 25,416
|
2,006
-1.0%
|
12.67
|
USD 25,416
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
1,784
-1.0%
11.91
USD 21,247
|
1,784
-1.0%
|
11.91
|
USD 21,247
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
1,642
-1.6%
11.91
USD 19,556
|
1,642
-1.6%
|
11.91
|
USD 19,556
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
1,642
-2.1%
11.91
USD 19,556
|
1,642
-2.1%
|
11.91
|
USD 19,556
|
|
2022-03-04 |
2022-03-03 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
1,787
-1.7%
11.38
USD 20,336
|
1,787
-1.7%
|
11.38
|
USD 20,336
|
|
2022-03-04 |
2022-03-03 |
PS
Planned sale
|
Reilly Thomas Charles
Chief Financial Officer
Officer
|
2,044
-5.1%
11.38
USD 23,261
|
2,044
-5.1%
|
11.38
|
USD 23,261
|
|
2022-03-01 |
2022-02-25 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
1,972
-1.9%
10.29
USD 20,292
|
1,972
-1.9%
|
10.29
|
USD 20,292
|
|
2022-03-01 |
2022-02-25 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
2,114
-1.2%
10.29
USD 21,753
|
2,114
-1.2%
|
10.29
|
USD 21,753
|
|
2022-03-01 |
2022-02-25 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
1,972
-2.5%
10.29
USD 20,292
|
1,972
-2.5%
|
10.29
|
USD 20,292
|
|
2021-11-16 |
2021-11-12 |
S
Sale
|
Ives Jeffrey L.
Non-Executive Director
|
8,180
-53.2%
16.04
USD 131,207
|
8,180
-53.2%
|
16.04
|
USD 131,207
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
1,000
-2.1%
17.15
USD 17,150
|
1,000
-2.1%
|
17.15
|
USD 17,150
|
|
2021-10-28 |
2021-10-27 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
1,000
-2.1%
15.00
USD 15,000
|
1,000
-2.1%
|
15.00
|
USD 15,000
|
|
2021-09-01 |
2021-08-30 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
1,759
-2.4%
14.20
USD 24,978
|
1,759
-2.4%
|
14.20
|
USD 24,978
|
|
2021-06-07 |
2021-06-07 |
PS
Planned sale
|
Posner Christopher
Non-Executive Director
|
2,304
-12.5%
13.04
USD 30,044
|
2,304
-12.5%
|
13.04
|
USD 30,044
|
|
2021-06-07 |
2021-06-07 |
PS
Planned sale
|
VOGELBAUM MARTIN
Non-Executive Director
|
8,640
-30.0%
13.05
USD 112,752
|
8,640
-30.0%
|
13.05
|
USD 112,752
|
|
2021-06-07 |
2021-06-07 |
PS
Planned sale
|
Ives Jeffrey L.
Non-Executive Director
|
2,520
-14.1%
13.05
USD 32,886
|
2,520
-14.1%
|
13.05
|
USD 32,886
|
|
2021-03-24 |
2021-03-22 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
3,000
-8.9%
19.65
USD 58,950
|
3,000
-8.9%
|
19.65
|
USD 58,950
|
|
2021-03-08 |
2021-03-05 |
PS
Planned sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
3,103
-0.3%
17.98
USD 55,792
|
3,103
-0.3%
|
17.98
|
USD 55,792
|
|
2021-03-08 |
2021-03-05 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
3,093
-8.4%
17.98
USD 55,612
|
3,093
-8.4%
|
17.98
|
USD 55,612
|
|
2021-03-08 |
2021-03-05 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
3,358
-2.7%
17.98
USD 60,377
|
3,358
-2.7%
|
17.98
|
USD 60,377
|
|
2021-03-08 |
2021-03-05 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
3,090
-5.7%
17.98
USD 55,558
|
3,090
-5.7%
|
17.98
|
USD 55,558
|
|
2021-02-25 |
2021-02-25 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
5,003
-4.3%
19.33
USD 96,708
|
5,003
-4.3%
|
19.33
|
USD 96,708
|
|
2021-02-25 |
2021-02-25 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
4,004
-8.3%
19.33
USD 77,397
|
4,004
-8.3%
|
19.33
|
USD 77,397
|
|
2021-02-25 |
2021-02-25 |
PS
Planned sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
11,729
-1.2%
19.33
USD 226,722
|
11,729
-1.2%
|
19.33
|
USD 226,722
|
|
2021-02-25 |
2021-02-25 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
3,372
-11.2%
19.33
USD 65,181
|
3,372
-11.2%
|
19.33
|
USD 65,181
|
|
2021-02-24 |
2021-02-22 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,000
-7.1%
19.73
USD 39,460
|
2,000
-7.1%
|
19.73
|
USD 39,460
|
|
2021-01-25 |
2021-01-21 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,000
-6.7%
20.12
USD 40,240
|
2,000
-6.7%
|
20.12
|
USD 40,240
|
|
2020-12-30 |
2020-12-30 |
PS
Planned sale
|
Terrillion Scott
Sec'y; Chief Compliance & G.C.
Officer
|
1,946
-4.4%
15.30
USD 29,774
|
1,946
-4.4%
|
15.30
|
USD 29,774
|
|
2020-12-30 |
2020-12-30 |
PS
Planned sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
6,078
-0.6%
15.30
USD 92,993
|
6,078
-0.6%
|
15.30
|
USD 92,993
|
|
2020-12-30 |
2020-12-30 |
PS
Planned sale
|
Menzaghi Frederique Ph.D.
Chief Scientific Off,SVP-R&D
Officer
|
2,812
-2.5%
15.30
USD 43,024
|
2,812
-2.5%
|
15.30
|
USD 43,024
|
|
2020-12-30 |
2020-12-30 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
1,298
-4.1%
15.30
USD 19,859
|
1,298
-4.1%
|
15.30
|
USD 19,859
|
|
2020-12-29 |
2020-12-28 |
PS
Planned sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
5,000
-0.5%
16.00
USD 80,000
|
5,000
-0.5%
|
16.00
|
USD 80,000
|
|
2020-12-23 |
2020-12-21 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,000
-6.8%
15.00
USD 30,000
|
2,000
-6.8%
|
15.00
|
USD 30,000
|
|
2020-12-18 |
2020-12-16 |
S
Sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
5,000
-0.5%
14.95
USD 74,750
|
5,000
-0.5%
|
14.95
|
USD 74,750
|
|
2020-12-11 |
2020-12-10 |
S
Sale
|
CHALMERS DEREK T
President & CEO
Executive Director
|
7,500
-0.8%
15.29
USD 114,675
|
7,500
-0.8%
|
15.29
|
USD 114,675
|
|
2020-11-25 |
2020-11-23 |
PS
Planned sale
|
Goncalves Joana
Chief Medical Officer
Officer
|
2,000
-6.4%
15.31
USD 30,620
|
2,000
-6.4%
|
15.31
|
USD 30,620
|
|
2020-11-23 |
2020-11-19 |
S
Sale
|
Posner Christopher
Non-Executive Director
|
2,000
-15.2%
15.82
USD 31,638
|
2,000
-15.2%
|
15.82
|
USD 31,638
|
|
2020-11-19 |
2020-11-17 |
S
Sale
|
VOGELBAUM MARTIN
Non-Executive Director
|
6,000
-29.4%
16.09
USD 96,540
|
6,000
-29.4%
|
16.09
|
USD 96,540
|
|